Content matching 'alzheimers'
Researchers at Massachusetts General Hospital and Harvard Stem Cell Institute have constructed 3D models of Alzheimer's disease with human neurons derived from induced stem cells of patients with early-onset Alzheimer's disease.
Noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat Parkinson's disease, stroke, MS, brain tumors, cerebral ischemia, Alzheimer's and other CNS disorders.
Regenerative medicine and therapeutic cell treatment of disorders of the brain and spinal cord are hindered by the blood-brain barrier. Invasive implantation of therapeutic cells in the brain, including stem cells and immune cells, is both risky and impractical. Noninvasive intranasal cell delivery to the CNS provides a solution to this problem.
Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle